Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

970
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
970
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

1.2K
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

627
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
627
What is the Skeletal System?01:02

What is the Skeletal System?

59.0K
Overview
59.0K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

618
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
618
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

8.7K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mineral, Bone, and Cardiovascular Disorders in CKD: The Case for a New Paradigm.

Kidney medicine·2026
Same author

Osteoporosis and CKD-Metabolic Bone Disease Under the Same Umbrella: Insights From a Joint Scientific Symposium.

Kidney international reports·2026
Same author

Treatment with romosozumab in patients with osteoporosis on maintenance hemodialysis.

Journal of bone and mineral metabolism·2026
Same author

Formation of Pyramidal Palladium Enhanced by B(C<sub>6</sub>F<sub>5</sub>)<sub>3</sub> Additive Enabling Selective Alkene Monoisomerization.

ACS omega·2026
Same author

Metal-Ligand Exchange Coupling Alters the Open-Shell Ligand Electronic Structure in a Bis(semiquinone) Complex.

Inorganic chemistry·2024
Same author

Variation from closed-shell to open shell electronic structures in oligothiophene bis(dioxolene) complexes.

Chemical science·2023

Related Experiment Video

Updated: Apr 5, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.9K

Chronic kidney disease and the skeleton.

Paul D Miller1

  • 1Colorado Center for Bone Research , Lakewood, CO, USA.

Bone Research
|August 15, 2015
PubMed
Summary

Fractures in chronic kidney disease (CKD) can stem from osteoporosis or CKD-mineral and bone disorder (CKD-MBD). Differentiating these conditions is crucial for effective fracture management across all CKD stages.

Area of Science:

  • Nephrology
  • Endocrinology
  • Orthopedics

Background:

  • Fractures in chronic kidney disease (CKD) patients are complex, potentially arising from osteoporosis, renal osteodystrophy, or CKD-mineral and bone disorder (CKD-MBD).
  • CKD-MBD encompasses metabolic disturbances in calcium, phosphorus, parathyroid hormone, and vitamin D, alongside bone abnormalities and calcifications.
  • Osteoporosis, defined by the NIH, can coexist with CKD-MBD, necessitating careful differentiation for appropriate patient care.

Purpose of the Study:

  • To review and clarify the diagnosis and management of fractures in patients across the five stages of CKD.
  • To highlight the challenges in diagnosing osteoporosis in later stages of CKD (stages 4 and 5).
  • To differentiate between osteoporosis, renal osteodystrophy, and CKD-MBD for optimal treatment strategies.

More Related Videos

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

2.7K
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

825

Related Experiment Videos

Last Updated: Apr 5, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.9K
A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

2.7K
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

825

Main Methods:

  • Review of diagnostic criteria for osteoporosis and CKD-MBD.
  • Analysis of biochemical markers (serum PTH, FGF23) and bone histomorphometry for diagnosis.
  • Examination of current treatment guidelines and evidence for managing fractures in CKD patients.

Main Results:

  • WHO osteoporosis criteria are applicable for CKD stages 1-3 but not for stages 4-5 due to altered bone turnover.
  • Diagnosis of osteoporosis in advanced CKD relies on excluding renal osteodystrophy and CKD-MBD.
  • Fracture management in early CKD stages mirrors that in non-CKD patients, provided CKD-MBD is absent; treatment in advanced CKD lacks robust evidence, with some therapies showing promise in stage 4.

Conclusions:

  • Accurate diagnosis of fracture etiology in CKD requires distinguishing between osteoporosis, renal osteodystrophy, and CKD-MBD.
  • Biochemical markers and bone histomorphometry are key to differentiating these conditions.
  • Evidence-based management strategies for fractures in advanced CKD are limited, underscoring the need for further research.